Company Profile
Complement Therapeutics Limited
12515463•Private Limited With Share Capital
Get Full Access
12/03/2020
6 years
3
—
72110
very low risk
Company Overview
Registration, classification & business activity
Complement Therapeutics Limited (12515463) is a private limited with share capital incorporated on 12/03/2020 (6 years old) and registered in london, W120BZ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Complement therapeutics (ctx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. the company is a spinout from the university of manchester and is based on the pioneering research of its founders into novel targets ...
Financial Overview
£11.65M
£3.17M
£8.48M
£4.75M
£6.67M
Key Metrics
3
Directors
1
Shareholders
2
Patents
Board of Directors
Innovate Grants
This company received a grant of £57161.0 for Aav Production Process Intensification Using Perfusion Bioreactor Technology. The project started on 01/05/2024 and ended on 30/04/2026.
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating